Skip to content

Healing, Equity, Advocacy and Respect for Mamas

Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06273436
Acronym
HEAR4Mamas
Enrollment
2894
Registered
2024-02-22
Start date
2024-05-28
Completion date
2030-03-30
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Complication

Keywords

AIM (Alliance for Innovation on Maternal Health) safety bundles, Randomized Controlled Trial (RCT), Emergency Department (ED) visits, Shared Decision Making (SDM), Patient-Reported Outcomes (PROs), Patient Stakeholder Group (PSG), Study Advisory Committee (SAC)

Brief summary

The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.

Detailed description

The purpose of the study is to learn if a program for newborn mom's can improve detection of complications after delivery and help women get medical care quickly and easily. Participants will be asked to complete a survey at the time of enrollment and at 3 additional times. All surveys can be completed via cell-phone or email. All women will be followed for 1-year after delivery. Women that enroll will be assigned to one of two groups: usual in person care OR usual in-person care PLUS a text message-based program that will ask about sign and symptoms of complications that may occur after delivery. If there is a concern, a nurse advocate will call on the phone to discuss options and help refer to care if needed. Participants will be paid for their time in completing surveys.

Interventions

OTHERH.E.A.R. for Mamas

H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

for Postpartum Women * Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina. * Aged 16-49 years old. * Insured by Medicaid.

Exclusion criteria

for Postpartum Women * Plans to relocate outside of SC anytime during the postpartum year. * Plans to discontinue Medicaid health insurance during the postpartum year. * Speaks a language other than English or Spanish. * Incarcerated/pending incarceration during peripartum period. * Currently institutionalized. * Enrolled in current MUSC study funded by PCORI (#Pro00123833) * Does not have and/or does not wish to use their personal cell phone for the study. Inclusion Criteria for Obstetric Providers and Hospital Administrators \- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit.

Design outcomes

Primary

MeasureTime frameDescription
Emergency Department (ED) visits within six weeks postpartumWithin six weeks following the deliveryPercent of postpartum women with an ED visit that occurs within six weeks following delivery

Secondary

MeasureTime frameDescription
Patient Reported Outcomes (PROs)time of study enrollment (baseline=0), and 3, 6, and 12 months postpartumSecondary outcomes will include PROs which will be measured at the time of study enrollment (baseline=0), and 3, 6, and 12 months postpartum.

Countries

United States

Contacts

CONTACTConstance Guille, MD
guille@musc.edu843-792-6489
CONTACTEdie Douglas
douglaed@musc.edu8439985635

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026